Cargando…

Von Willebrand factor:antigen and ADAMTS-13 level, but not soluble P-selectin, are risk factors for the first asymptomatic deep vein thrombosis in cancer patients undergoing chemotherapy

BACKGROUND: There is a high incidence of deep vein thrombosis (DVT) among cancer patients undergoing chemotherapy. Chemotherapy-induced vascular endothelial cell activation (VECA) is characterized by increased plasma levels of von Willebrand factor (vWF) and soluble P-selectin (sP-selectin), leading...

Descripción completa

Detalles Bibliográficos
Autores principales:	Setiawan, Budi, Permatadewi, Cecilia Oktaria, de Samakto, Baringin, Bugis, Ashar, Naibaho, Ridho M., Pangarsa, Eko Adhi, Santosa, Damai, Suharti, Catharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659107/ https://www.ncbi.nlm.nih.gov/pubmed/33292287 http://dx.doi.org/10.1186/s12959-020-00247-6

Ejemplares similares

Establishing the hematopoietic stem cell transplant (HSCT) in a developing country; the journey of HSCT in Semarang, Indonesia
por: Santosa, Damai, et al.
Publicado: (2020)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin's Lymphoma
por: Pangarsa, Eko A., et al.
Publicado: (2021)

Clinical Evaluation for the Role of High-Sensitivity C-Reactive Protein in Combination with D-Dimer and Wells Score Probability Test to Predict the Incidence of Deep Vein Thrombosis Among Cancer Patients
por: Setiawan, Budi, et al.
Publicado: (2020)

Preliminary study of hypoxia markers in diffuse large B-cell lymphoma
por: Pangarsa, Eko A., et al.
Publicado: (2022)

The expression of hypoxia inducible factor-1 alpha in diffuse large B-cell lymphoma (DLBCL) patients: a cross-sectional study in Indonesia
por: Pangarsa, Eko Adhi, et al.
Publicado: (2023)

Correlation of Inflammation and Coagulation Markers with the Incidence of Deep Vein Thrombosis in Cancer Patients with High Risk of Thrombosis
por: Setiawan, Budi, et al.
Publicado: (2022)

Curcumin as adjuvant therapy to improve remission in myeloma patients: A pilot randomized clinical trial
por: Santosa, Damai, et al.
Publicado: (2022)

A full-term pregnant woman with secondary Evans syndrome caused by severe coronavirus disease 2019: a case report
por: Santosa, Damai, et al.
Publicado: (2021)

The effect of multidisciplinary team on survival rates of women with breast cancer: a systematic review and meta-analysis
por: Pangarsa, Eko A., et al.
Publicado: (2023)

The effectiveness of atorvastatin for the prevention of deep vein thrombosis in cancer patients undergoing chemotherapy: A randomised controlled trial: open label
por: Setiawan, Budi, et al.
Publicado: (2023)

The von Willebrand factor – ADAMTS‐13 axis in malaria
por: O’Donnell, Andrew S., et al.
Publicado: (2022)

Impact of independent multidisciplinary work on the survival rate of stage 3 and 4 nasopharyngeal cancer in Indonesia: a retrospective cohort study
por: Rizky, Daniel, et al.
Publicado: (2023)

SARS-CoV-2 Breakthrough Infection after mRNA-1273 Booster among CoronaVac-Vaccinated Healthcare Workers
por: Santi, Theresia, et al.
Publicado: (2022)

ADAMTS‐13 and von Willebrand factor: a dynamic duo
por: South, K., et al.
Publicado: (2017)

Von Willebrand factor, ADAMTS13 and mortality in dialysis patients
por: Ocak, Gurbey, et al.
Publicado: (2021)

Proteolytic Processing of Von Willebrand Factor by Adamts13 and Leukocyte Proteases
por: Lancellotti, Stefano, et al.
Publicado: (2013)

Biological variations of ADAMTS13 and von Willebrand factor in human adults
por: Kilercik, Meltem, et al.
Publicado: (2014)

Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis
por: Birnie, Emma, et al.
Publicado: (2017)

The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
por: Reardon, Benjamin, et al.
Publicado: (2021)

The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer
por: Colonne, Chanukya K., et al.
Publicado: (2022)

ADAMTS‐13 and bleeding phenotype in von Willebrand disease
por: Boender, Johan, et al.
Publicado: (2020)

Correction: Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis
por: Birnie, Emma, et al.
Publicado: (2020)

Von Willebrand Factor and ADAMTS-13 Are Associated with the Severity of COVID-19 Disease
por: Dolgushina, Nataliya, et al.
Publicado: (2022)

ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients
por: Escher, R., et al.
Publicado: (2020)

Severe Dengue Is Associated with Consumption of von Willebrand Factor and Its Cleaving Enzyme ADAMTS-13
por: Djamiatun, Kis, et al.
Publicado: (2012)

Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease
por: Soares, R.P.S., et al.
Publicado: (2013)

A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von willebrand factor
por: South, Kieron, et al.
Publicado: (2017)

Histone-induced thrombotic thrombocytopenic purpura in adamts13(−/−) zebrafish depends on von Willebrand factor
por: Zheng, Liang, et al.
Publicado: (2020)

Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13
por: Yang, Junxian, et al.
Publicado: (2020)

Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients
por: Singh, Kanwal, et al.
Publicado: (2021)

Quantification of von Willebrand factor and ADAMTS-13 after traumatic injury: a pilot study
por: MacArthur, Taleen A, et al.
Publicado: (2021)

Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19
por: Marco, A, et al.
Publicado: (2021)

Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation
por: Wysokinski, Waldemar E., et al.
Publicado: (2020)

Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension
por: Ahmed, Abdulla, et al.
Publicado: (2021)

Secretion of von Willebrand Factor and Suppression of ADAMTS-13 Activity by Markedly High Concentration of Ferritin
por: Bashir, Dalia A., et al.
Publicado: (2021)

Characterization of Conformation-Sensitive Antibodies to ADAMTS13, the von Willebrand Cleavage Protease
por: Sauna, Zuben E., et al.
Publicado: (2009)

Evaluation of Usability and User Experience of Oncodoc ‘s M-Health Application for Early Detection of Cancer
por: Wulandari, Respati, et al.
Publicado: (2022)

Effect of Vitamin D Status on Von Willebrand Factor and ADAMTS13 in Diabetic Patients on Chronic Hemodialysis
por: Cohen-Hagai, Keren, et al.
Publicado: (2017)

Von Willebrand factor and ADAMTS13 activity in relation to risk of dementia: a population-based study
por: Wolters, Frank J., et al.
Publicado: (2018)

Role of von Willebrand factor and ADAMTS‐13 in early brain injury after experimental subarachnoid hemorrhage
por: Wan, H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_98af23a9e0v7fj4q7ute6gj1rt